PKCα and PKCδ Regulate ADAM17-Mediated Ectodomain Shedding of Heparin Binding-EGF through Separate Pathways
2011

How PKCα and PKCδ Regulate Shedding of Heparin Binding-EGF

publication 10 minutes Evidence: moderate

Author Information

Author(s): Marie Kveiborg, Rachael Instrell, Christina Rowlands, Michael Howell, Peter J. Parker

Primary Institution: Cancer Research UK, London Research Institute

Hypothesis

The study investigates the molecular mechanisms of PKC-dependent ectodomain shedding of EGFR-ligands.

Conclusion

The study found that PKCα and PKCδ regulate the shedding of HB-EGF through separate but cooperative pathways.

Supporting Evidence

  • PMA treatment triggers a rapid release of HB-EGF mediated by ADAM17.
  • PKCα specifically regulates PMA-induced shedding of HB-EGF.
  • PKCδ and ERK influence both constitutive and inducible shedding of HB-EGF.
  • Combined inactivation of PKCα and PKCδ results in total blockage of HB-EGF shedding.

Takeaway

This study shows that two proteins, PKCα and PKCδ, help control how a growth factor is released from cells, which is important for cancer growth.

Methodology

The study used a cell-based system to analyze PMA-induced shedding of HB-EGF and employed various inhibitors and siRNA for specific protein knockdown.

Limitations

The study does not explore the role of other potential ADAMs in HB-EGF shedding beyond ADAM17.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017168

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication